Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Michael Wang
Mar 31, 2024, 23:07 |
Blog
Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
Aug 12, 2024, 01:20 |
Blog
Using CRISPR technology to enhance CAR-T cells
Patrick Hwu shared on X: "How do we make more effective CAR-T cells? The Marco Ruella…
Jul 17, 2024, 05:10 |
Insight
The ideal combination partner for BiTE therapy
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Jun 29, 2024, 16:57 |
Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 20, 2024, 10:10 |
Insight
Date of improved response rates in mantle cell lymphoma patients
MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…
Sep 24, 2024, 12:30 |
Societies
11 ESMO24 presentations published on NEJM
At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…
Sep 17, 2024, 16:15 |
Blog
Median overall survival in melanoma with nivolumab plus ipilimumab presented at ESMO24 - NEJM
NEJM posted the following on X: “Presented at ESMO24: Among patients with advanced melanoma, median…
Sep 14, 2024, 15:18 |
Insight
Francisco Esteva: AI reader is making strides in mammographic screening for breast cancer
Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
Sep 6, 2024, 11:26 |
Insight
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes
International Urology Cancer Summit made the following post on X: "Non-BRCA1/2 HRR mutations might benefit…
Sep 5, 2024, 12:26 |
Blog
How does pathologic response following neoadjuvant chemotherapy affect survival/recurrence in PCAD
Anirban Maitra shared on X: "Pathologic complete response following neoadjuvant chemotherapy in Pancreatic Cancer: Impact on…
1
2
3
4
5
All:
42
Posts:
11 - 20
ASTRO24: 20 Posts Not To Miss From Day 1
Fran Drescher and Uterine Cancer: How She Went Against, How She Survived, and More
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube